Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
LY3143921 is an ATP-competitive CDC7 inhibitor that inhibits cell-cycle progression, which may lead to anti-tumor activity (J Clin Oncol 37, 2019 (suppl; abstr TPS3167)).
|CAS Registry Number||1627696-53-0|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|